mitoxantrone has been researched along with Urinary Retention in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Urinary Retention: Inability to empty the URINARY BLADDER with voiding (URINATION).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Au, WY | 1 |
Mak, W | 1 |
Ho, SL | 1 |
Leung, SY | 1 |
Kwong, YL | 1 |
1 other study available for mitoxantrone and Urinary Retention
Article | Year |
---|---|
Reversible paraneoplastic neuropathy associated with T-cell large granular lymphocyte leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclosporine; Dexamethasone; Female; Humans; | 2004 |